Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 2104-2110
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2104
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2104
Prospective group (n = 57) | Retrospective group (n = 613) | P value | |
Age (yr) | 52.4 (17-94) | 58.9 (5-96) | 0.062 |
Gender (M:F) | 35 (61):22 (39) | 320 (52):293 (48) | 0.179 |
Comorbidity | |||
None | 14 (25) | 219 (36) | |
Heart disease | 13 (23) | 127 (21) | |
Hypertension | 19 (33) | 170 (28) | |
Pulmonary disease | 5 (9) | 69 (11) | |
Diabetes mellitus | 4 (7) | 57 (9) | |
Previous pancreatitis | 15 (26) | 38 (6) | < 0.001 |
Duration of pain (h) | 24 (0-504) | 20 (0-0.592) | |
Severe pancreatitis | |||
CRP | 31 (54) | 276 (45) | 0.975 |
CT | 3 (10) | 33 (10) | 0.945 |
Complications | 0.660 | ||
None | 45 (79) | 497 (81) | |
Systemic | 8 (14) | 89 (14.9) | |
Local | 4 (7) | 43 (7.2) | |
Mortality | 1 (2) | 36 (6) | 0.356 |
Severity of pancreatitis | 0.713 | ||
Mild | 50 (88) | 521 (85) | |
Moderate severe | 2 (4) | 54 (9) | |
Severe | 5 (8) | 38 (6) |
- Citation: Rashidi M, Røkke O. Prospective evaluation of the cause of acute pancreatitis, with special attention to medicines. World J Gastroenterol 2016; 22(6): 2104-2110
- URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2104.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2104